Jefferies analyst Anthony Linton maintained a Buy rating on Tourmaline Oil (TOU – Research Report) today and set a price target of C$78.00. The ...
Tourmaline Oil Corp. closed 7.6% below its 52-week high of C$70.83, which the company reached on February 21st.
Tourmaline strategically pivoted from natural gas to liquids production amid pricing challenges. See why we believe TRMLF ...
Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease over-enrolled to 143 total ...
Tourmaline Bio (NASDAQ:TRML – Get Free Report) had its price objective lifted by analysts at HC Wainwright from $49.00 to $50.00 in a research report issued on Friday,Benzinga reports. The firm ...
Tourmaline Oil Corp. closed 8.2% below its 52-week high of C$70.83, which the company achieved on February 21st.
TOURMALINE BIO ($TRML) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.86 per share, beating estimates of -$0.89 by $0 ...
Readers hoping to buy Tourmaline Oil Corp. ( TSE:TOU ) for its dividend will need to make their move shortly, as ...
Analysts at Wedbush issued their FY2024 EPS estimates for shares of Tourmaline Bio in a research note issued on Thursday, March 6th. Wedbush analyst L. Chico expects that the company will post ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results